Australian medical fund takes research consultations on the road

26 July 2016

Consultation meetings are taking place around Australia from this week to develop the Medical Research Future Fund (MRFF) strategy and priorities, and the country’s future research infrastructure priorities.

Australia’s MRFF has been set up to provide grants to support health and medical research and innovation, with the objective of improving the health and wellbeing of Australians, and these sessions are a chance to hear from the advisory board on the outcomes of the written submission component of the public consultation that was completed in June.

The board is also outlining the draft framework that has been developed for the MRFF, an initiative which trade group AusBiotech has publicly congratulated the government on, as well as supporting a portion of the fund being directed to Australian companies commercializing discoveries in the life sciences via the Biomedical Translational Fund.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK